Abstract
Dyslipidaemia is a modifiable cause of increased mortality in patients with mental illness. We described prevalence, aetiology and treatment of dyslipidaemia in patients with mental illness. Patients with mental illness have a higher prevalence of dyslipidaemia than the general population due to genetic predisposition, unhealthy lifestyle and/or psychotropic medications. Attention towards early identification of dyslipidaemia, close monitoring, and a low threshold for initiating treatment with lifestyle interventions and lipid-lowering agents are warranted in patients with mental illness.
| Original language | English |
|---|---|
| Journal | Ugeskrift for Laeger |
| Volume | 184 |
| Issue number | 10 |
| ISSN | 0041-5782 |
| Publication status | Published - 7 Mar 2022 |
Fingerprint
Dive into the research topics of 'Dyslipidaemia in patients with mental illness'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS